These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36096976)

  • 1. Executive summary: Japanese guidelines for allergic conjunctival diseases 2021.
    Miyazaki D; Fukushima A; Uchio E; Shoji J; Namba K; Ebihara N; Takamura E; Fukuda K; Matsuda A; Okamoto S; Fukagawa K; Fujishima H; Ohno S; Ohashi Y;
    Allergol Int; 2022 Oct; 71(4):459-471. PubMed ID: 36096976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese guidelines for allergic conjunctival diseases 2020.
    Miyazaki D; Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Satake Y; Shoji J; Namba K; Fukagawa K; Fukushima A; Fujishima H; ;
    Allergol Int; 2020 Jul; 69(3):346-355. PubMed ID: 33211650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese guidelines for allergic conjunctival diseases 2017.
    Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Kumagai N; Satake Y; Shoji J; Nakagawa Y; Namba K; Fukagawa K; Fukushima A; Fujishima H;
    Allergol Int; 2017 Apr; 66(2):220-229. PubMed ID: 28209324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese guideline for allergic conjunctival diseases.
    Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Kumagai N; Satake Y; Shoji J; Nakagawa Y; Namba K; Fukagawa K; Fukushima A; Fujishima H;
    Allergol Int; 2011 Mar; 60(2):191-203. PubMed ID: 21636966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GUIDELINES FOR THE CLINICAL MANAGEMENT OF ALLERGIC CONJUNCTIVAL DISEASE THE POINT OF THE MANAGEMENT WITH USING CONVENTIONAL TOOL AND EYE DROPS].
    Takamura E
    Arerugi; 2018; 67(2):103-107. PubMed ID: 29553108
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic ocular disorders: a spectrum of diseases.
    Ehlers WH; Donshik PC
    CLAO J; 1992 Apr; 18(2):117-24. PubMed ID: 1606674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ophthalmology].
    Takamura E
    Nihon Rinsho; 2009 Nov; 67(11):2157-61. PubMed ID: 19899534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P; Kosrirukvongs P
    Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TREATMENT OF SEVERE ALLERGIC CONJUNCTIVITIS IN JAPAN, FOCUS ON IMMUNOSUPPRESSIVE EYE DROPS].
    Ebihara N
    Arerugi; 2021; 70(8):942-947. PubMed ID: 34588353
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular allergic disease.
    Stahl JL; Barney NP
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):455-9. PubMed ID: 15349048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
    Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S
    Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential Biomarkers for Allergic Conjunctival Diseases.
    Roy N; Levanon S; Asbell PA
    Eye Contact Lens; 2020 Mar; 46 Suppl 2(Suppl 2):S109-S121. PubMed ID: 32097185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the efficacy of subjective symptoms, objective findings, and of a total tear IgE detection kit in diagnosis of allergic conjunctival diseases].
    Shojio J; Uchio E; Ebihara N; Ohashi Y; Ohno S; Okamoto S; Kumagai N; Satake Y; Namba K; Fukagawa K; Fukushima A; Fujishima H; Takamura E
    Nippon Ganka Gakkai Zasshi; 2012 May; 116(5):485-93. PubMed ID: 22690539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic conjunctivitis: current concepts on pathogenesis and management.
    Sacchetti M; Abicca I; Bruscolini A; Cavaliere C; Nebbioso M; Lambiase A
    J Biol Regul Homeost Agents; 2018; 32(1 Suppl. 1):49-60. PubMed ID: 29552874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Knowledge in Allergic Conjunctivitis.
    Villegas BV; Benitez-Del-Castillo JM
    Turk J Ophthalmol; 2021 Feb; 51(1):45-54. PubMed ID: 33631915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy for ocular allergy.
    Trocme SD; Raizman MB; Bartley GB
    Mayo Clin Proc; 1992 Jun; 67(6):557-65. PubMed ID: 1359206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease.
    Calder VL; Jolly G; Hingorani M; Adamson P; Leonardi A; Secchi AG; Buckley RJ; Lightman S
    Clin Exp Allergy; 1999 Sep; 29(9):1214-22. PubMed ID: 10469030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.